Antihypertensive effects of angiotensin converting enzyme inhibition by lisinopril in post-transplant patients

American Journal of Hypertension

Volumn 15, Issue 10 I, 2002, Pages 911-916

  Opie, Lionel H ^a,c   Haus, Matthias ^b   Commerford, Patrick J ^a   Levetan, Basil ^a   Moore, Karen ^a   Brink, Johan ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Left ventricular mass; Lisinopril; Transplant hypertension

Indexed keywords

AMLODIPINE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL; PLACEBO;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRONCHOPNEUMONIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY HEMODYNAMICS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ECHOCARDIOGRAPHY; ENZYME INHIBITION; FEMALE; GRAFT REJECTION; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE; HEART TRANSPLANTATION; HEART VENTRICLE VOLUME; HUMAN; HYPERTENSION; KAPOSI SARCOMA; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART TRANSPLANTATION; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; LISINOPRIL; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 0036795723     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(02)02992-8     Document Type: Article

References (25)

1. Starling RC, Cody RJ: Cardiac transplant hypertension. Am J Coll Cardiol 1990;65:106-111.
2. Jenkins JT, Boyle JJ, McKay IC, Richens D, McPhaden AR, Lindop GBM: Vascular remodelling in intramyocardial resistance vessels in hypertensive human cardiac transplant recipients. Heart 1997;77:353-356.
3. Dählof B, Pennert K, Hansson L: Reversal of left ventricular hypertrophy in hypertensive patients. A meta-analysis of 109 treatment studies. Am J Hypertens 1992;5:95-110.
4. Brilla C, Funck RC, Rupp H: Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000;102:1388-1393.
5. Touyz RM, Schiffrin EL: Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 2000;52:639-672.
6. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med 1990;322:1561-1566.
7. Bracht C, Yan X-W, LaRocca H-PB, Sutsch G, Kiowski W: Cyclosporine A and control of vascular tone in the human forearm: influence of post-transplant hypertension. J Hypertens 1999;17:357-363.
8. Singer DRJ, Jenkins GH: Hypertension in transplant recipients. J Hum Hypertens 1996;10:395-402.
9. Asmar RG, Pannier B, Santoni JP, Laurent S, London GM, Levy BI, Safar ME: Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. Circulation 1988;78:941-950.
10. Brozena SC, Johnson MR, Ventura H, Hobbs R, Miller L, Olivari MT, Clemson B, Bourge R, Quigg R, Mills R Jr, Naftel D: Effectiveness and safety of diltiazem or lisinopril in treatment of hypertension after heart transplantation. J Am Coll Cardiol 1996;27:1707-1712.
11. Holm T, Andreassen AK, Aukrust P, Andersen K, Geiran OR, Kjeks J, Simonsen S, Gullestad L: Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Eur Heart J 2001;22:428-436.
12. Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C: Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 1990; 81:528-536.
13. Devereux RB, James GD, Pickering TG: What is normal blood pressure? Comparison of ambulatory pressure level and variability in patients with normal or abnormal left ventricular geometry. Am J Hypertens 1993;6(Suppl):211S-215S.
14. Staessen J, Bert P, Bulpitt C, De Cort P, Fagard R, Fletcher A: Nitrendipine in older patients with isolated systolic hypertension: second progress report on the SYST-EUR trial. J Hum Hypertens 1993;7:265-271.
15. Reeves RA, Shapiro AP, Thompson ME, Johnsen A-M: Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 1986;3:401-408.
16. Mancia G, Sega R, Grassi G, Cesana G, Zanchetti A: Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study. J Hypertens 2001;19:995-999.
17. Ohkubo T, Imai Y, Tsuji I, Nagai K, Ito S, Satoh H, Hisamichi S: Reference values for 24-hour ambulatory blood pressure monitoring based on a prognostic criterion. The Ohasama Study. Hypertension 1998;32:255-259.
18. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ: The Registry of the International Society of Heart and Lung Transplantation: Seventeenth Official Report-2000. J Heart Lung Transplant 2000;19:909-931.
19. Angermann CE, Spes CH, Willems S, Dominak P, Kemkes BM, Theisen K: Regression of left ventricular hypertrophy in hypertensive heart transplant recipients treated with enalapril, furosemide and verapamil. Circulation 1991;84:583-593.
20. Tischler MD, Lee RT, Plappert T, Mudge GH, St John Sutton M, Parker JD: Serial assessment of left ventricular function and mass after orthotopic heart transplantation: a 4-year longitudinal study. J Am Coll Cardiol 1992;19:60-66.
21. Armstrong AT, Binkley PF, Baker BP, Myerowitz PD, Leier CV: Quantitative investigation of cardiomyocyte hypertrophy and myocardial fibrosis over 6 years after cardiac transplantation. J Am Coll Cardiol 1998;32:704-710.
22. Schwarzacher SP, Uren NG, Ward MR, Schwarzkopf A, Giannetti N, Hunt S, Fitzgerald PJ, Oesterle SN, Yeung AC: Determinants of coronary remodeling in transplant coronary disease. Circulation 2000;101:1384-1389.
23. Novitsky D, Cooper D, Boniaszczuk J, Isaacs S, Fraser RC, Commerford PJ, Uys CJ, Rose AG, Smith JA, Barnard CN: The significance of left ventricular volume measurement after heart transplantation using radionuclide techniques. Heart Transplant 1985;IV:206-209.
24. Stetson SJ, P-Verdia A, Mazur W, Farmer JA, Koerner MM, Weilbaecher DG, Entman ML, Quifiones MA, Noon GP, Torre-Amione G: Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor α. Circulation 2001;104:678-681.
25. Hollenberg SM, Klein LW, Parrillo JE, Scherer M, Burns D, Tamburro P, Oberoi M, Johnson MR, Costanzo MR: Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 2001;104:3091-3096.